{
    "nct_id": "NCT03081884",
    "official_title": "Validation of FACBC as an Early Indicator of Sub-clinical Metastatic Disease Among High-risk Prostate Cancer Patients With Presumed Localized Disease",
    "inclusion_criteria": "* High-risk prostate cancer patients eligible for standard of care surgery\n\n  * At least clinical T3a disease, and/or Gleasonâ‰¥8, and/or Prostate-Specific Antigen (PSA) >20, as per clinical assessment and routine guidelines\n* Undergone standard of care conventional imaging (CT and/or MRI; bone scan and/or sodium fluoride (NaF) PET)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Definitive findings of systemic metastasis on conventional imaging.",
    "miscellaneous_criteria": ""
}